According to McKesson's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 32.4294. At the end of 2023 the company had a P/E ratio of 20.8.
Year | P/E ratio | Change |
---|---|---|
2023 | 20.8 | 22.2% |
2022 | 17.1 | -38.33% |
2021 | 27.6 | -526.7% |
2020 | -6.48 | -77.19% |
2019 | -28.4 | -65.8% |
2018 | -83.1 | -1311.15% |
2017 | 6.86 | -58.3% |
2016 | 16.4 | -29.29% |
2015 | 23.3 | -16.97% |
2014 | 28.0 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() Cardinal Health CAH | 24.5 | -24.52% | ๐บ๐ธ USA |
![]() AmerisourceBergen
ABC | 21.7 | -33.05% | ๐บ๐ธ USA |
![]() Henry Schein
HSIC | 21.6 | -33.33% | ๐บ๐ธ USA |
![]() Veradigm MDRX | 9.30 | -71.32% | ๐บ๐ธ USA |
![]() Cerner CERN | 47.5 | 46.35% | ๐บ๐ธ USA |
![]() Computer Programs and Systems CPSI | 27.8 | -14.13% | ๐บ๐ธ USA |
![]() Owens & Minor
OMI | -1.57 | -104.84% | ๐บ๐ธ USA |
![]() Patterson Companies
PDCO | 20.1 | -38.07% | ๐บ๐ธ USA |
![]() Premier PINC | -60.7 | -287.13% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.